How an ObamaCare repeal vote could actually be good for Democrats


Democrats see a certain advantage to House Republicans successfully voting to repeal ObamaCare and it has nothing to do with any fondness for the proposed replacement, Politico reports. Instead, certain Democrats believe there is an opportunity to take back the House in the 2018 midterms if House Republicans pass their controversial bill, just as Republicans managed to do in 2010 when they channeled national anti-ObamaCare sentiment.
"I think there will be a political price to pay at the ballot box in 2018," observed Rep. Linda Sánchez (D-Calif.).
Politico breaks it down:
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Democrats don't actually want the law repealed. Under their dream scenario, House GOP leaders would muscle through their controversial health-care bill only to watch it die a long, painful death in the Senate, where it has already received a lukewarm reception from Republicans. ObamaCare would stay intact while the House Republicans who voted to gut the law have a big shiny target on their back heading into the 2018 midterms. [Politico]
Many ObamaCare provisions are popular with both parties, such as federal requirements for customers with pre-existing conditions, and advertisements skewering Republicans for dropping such protections are already hitting the airwaves. "The attack ads write themselves, Democrats argue. And they are betting the House on it," Politico writes. Jeva Lange
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Jeva Lange was the executive editor at TheWeek.com. She formerly served as The Week's deputy editor and culture critic. She is also a contributor to Screen Slate, and her writing has appeared in The New York Daily News, The Awl, Vice, and Gothamist, among other publications. Jeva lives in New York City. Follow her on Twitter.
-
Gaza is running out of cash
Under The Radar Palestinians pay the price as black market springs up around banknotes and coins
By Elizabeth Carr-Ellis, The Week UK Published
-
Law firms: Caving to White House pressure
Feature Trump targets major law firms tied to his past investigations
By The Week US Published
-
Venezuelan deportees: Locked up for tattoos?
Feature A former pro soccer player was deported after U.S. authorities claimed his tattoo proved he belonged to a Venezuelan gang
By The Week US Published
-
Measles outbreak spreads, as does RFK Jr.'s influence
Speed Read The outbreak centered in Texas has grown to at least three states and Health Secretary Robert F. Kennedy Jr. is promoting unproven treatments
By Peter Weber, The Week US Published
-
RFK Jr. offers alternative remedies as measles spreads
Speed Read Health secretary Robert F. Kennedy Jr. makes unsupported claims about containing the spread as vaccine skepticism grows
By Peter Weber, The Week US Published
-
Texas outbreak brings 1st US measles death since 2015
Speed read The outbreak is concentrated in a 'close-knit, undervaccinated' Mennonite community in rural Gaines County
By Rafi Schwartz, The Week US Published
-
Mystery illness spreading in Congo rapidly kills dozens
Speed Read The World Health Organization said 53 people have died in an outbreak that originated in a village where three children ate a bat carcass
By Peter Weber, The Week US Published
-
Ozempic can curb alcohol cravings, study finds
Speed read Weight loss drugs like Ozempic and Wegovy may also be helpful in limiting alcohol consumption
By Peter Weber, The Week US Published
-
New form of H5N1 bird flu found in US dairy cows
Speed Read This new form of bird flu is different from the version that spread through herds in the last year
By Peter Weber, The Week US Published
-
Microplastics accumulating in human brains, study finds
Speed Read The amount of tiny plastic particles found in human brains increased dramatically from 2016 to 2024
By Peter Weber, The Week US Published
-
FDA approves painkiller said to thwart addiction
Speed Read Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years
By Rafi Schwartz, The Week US Published